Fluorescent In-Situ Hybridization (FISH) for BCR/ABL in Chronic Myeloid Leukemia After Bone Marrow Transplantation

Sao Paulo Medical Journal- Brazil

doi 10.1590/s1516-31802001000100005

Full Text

Abstract

Available in

Categories

Medicine

Date

Authors

Publisher

FapUNIFESP (SciELO)

Related search

Evaluation of Early Hospital Discharge After Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia

Sao Paulo Medical Journal
Medicine
2007English

Revisiting the Need for Bone Marrow Examination in Chronic Myeloid Leukemia

American Journal of Hematology
Hematology
2017English

Acute Myeloid Leukemia With BCR/ABL Fusion Chimera

Indian Journal of Hematology and Blood Transfusion
Hematology
2014English

Targeting RSK2 in Myeloid Leukemia: Right for FLT3 but Wrong for BCR-ABL

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2011English

The Vascular Bone Marrow Niche Influences Outcome in Chronic Myeloid Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Management of Chronic Myeloid Leukemia With BCR/ABL Inhibitors: Current Status and Future Perspectives

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2010English

Adoptive Immunotherapy of BCR-ABL-induced Chronic Myeloid Leukemia-Like Myeloproliferative Disease in a Murine Model

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Infusion of BCR/Abl Peptide-Reactive Donor T Cells to Achieve Molecular Remission of Chronic Myeloid Leukemia After CD34+ Selected Allogeneic Hematopoietic Cell Transplantation

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Chronic Myeloid Leukemia With an E1a3 BCR-ABL Fusion Protein: Transformation to Lymphoid Blast Crisis

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy